Home / KITLG Knockout Cell Lines

KITLG Knockout Cell Lines

Gene: KITLG

Official Full Name: KIT ligandprovided by HGNC

Gene Summary: This gene encodes the ligand of the tyrosine-kinase receptor encoded by the KIT locus. This ligand is a pleiotropic factor that acts in utero in germ cell and neural cell development, and hematopoiesis, all believed to reflect a role in cell migration. In adults, it functions pleiotropically, while mostly noted for its continued requirement in hematopoiesis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00560 KITLG Knockout cell line (HCT 116) Human KITLG 1:2~1:4 Negative Online Inquiry
KO00561 KITLG Knockout cell line (HEK293) Human KITLG 1:3~1:6 Negative Online Inquiry
KO10729 KITLG Knockout cell line (HeLa) Human KITLG 1:3~1:6 Negative Online Inquiry
KO10730 KITLG Knockout cell line (A549) Human KITLG 1:3~1:4 Negative Online Inquiry

Background

KITLG Gene Knockout Cell Lines are specialized cellular models designed for the study of the Kit ligand (KITLG) gene and its associated signaling pathways, which play a crucial role in various biological processes including hematopoiesis, melanogenesis, and reproductive functions. These cell lines are engineered using CRISPR/Cas9 technology to create precise deletions or mutations within the KITLG gene, allowing researchers to investigate the functional consequences of KITLG loss-offunction in vitro.

The primary function of KITLG gene knockout cell lines lies in their ability to facilitate detailed examinations of KITLG's role in cellular growth, differentiation, and survival. By providing a controlled environment devoid of KITLG activity, these models enable scientists to assess the downstream effects on signaling cascades such as the receptor tyrosine kinase pathway. This functional dissection has significant implications for understanding cancers and disorders where KITLG signaling is disrupted.

Scientifically, KITLG gene knockout cell lines are invaluable in both research and clinical applications. They pave the way for drug discovery efforts targeting KITLG-related pathways and contribute to the elucidation of molecular mechanisms underlying diseases like melanoma and certain blood disorders. Additionally, these cell lines can aid in the development of targeted therapies that modulate KITLG activity, thus fostering potential clinical applications.

One of the unique advantages of KITLG gene knockout cell lines compared to traditional models is their specificity and the ease of use provided by CRISPR technology. Unlike knockout models generated through more labor-intensive transgenic approaches, our cell lines are readily accessible for high-throughput screening and functional assays, significantly reducing time and resource expenditures for researchers.

These knockout cell lines are indispensable tools for scientists looking to deepen their understanding of KITLG-mediated signaling and its pathological consequences. Our commitment to precision and innovation sets our offerings apart; with extensive expertise in cell line development and genetic modification, our products empower researchers and clinicians to push the boundaries of knowledge in molecular biology and therapeutic development. By utilizing KITLG Gene Knockout Cell Lines, users position themselves at the forefront of cutting-edge research with tangible implications in health and disease.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.